Purchases and Sales Made in Q3 2022 in T Scan Therapeutics, Inc. (TCRX)
This table provides information about the institutional ownership of T Scan Therapeutics, Inc. (TCRX) during Q3 2022. The information is specifically focused on institutions that hold shares of TScan Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
66.6K+ 195.21% |
$174K - $292K
|
101K
$243K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
31.4K+ 13.87% |
$82.1K - $138K
|
257K
$620K
|
|
|
Nov 01, 2022
Q3 2022
|
Privium Fund Management (Uk) LTD
|
BUY
|
- |
15.8KNew |
$41.5K - $69.5K
|
15.8K
$38.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Cannell Capital LLC
Alta, WY |
BUY
|
- |
11K+ 301.37% |
$28.9K - $48.3K
|
14.7K
$35.3K
|
|
|
Nov 04, 2022
Q3 2022
|
Prudential Financial Inc
Newark, NJ |
BUY
|
- |
11KNew |
$28.8K - $48.3K
|
11K
$26.5K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
7.48K+ 13.1% |
$19.6K - $32.8K
|
64.6K
$156K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
2.29K+ 199.74% |
$6.01K - $10.1K
|
3.44K
$8.29K
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
184New |
$482 - $808
|
184
$443
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
26+ 56.52% |
$68.1 - $114
|
72
$174
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-1K- 6.25% |
$2.62K - $4.39K
|
15K
$36.2K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.15K- 0.08% |
$3.01K - $5.04K
|
1.51M
$3.65M
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.98K- 33.06% |
$7.82K - $13.1K
|
6.04K
$14.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Newtyn Management, LLC
New York, NY |
SELL
|
- |
-48.6K- 19.55% |
$127K - $213K
|
200K
$482K
|
|
|
Nov 14, 2022
Q3 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-65.7K- 49.67% |
$172K - $288K
|
66.6K
$161K
|